Abstract
The alpha-glucosidase inhibitor voglibose (VO) was recently reported to have a protective effect against weight gain as well as affect various metabolic changes related to food intake and gut-brain signaling. We hypothesized that VO prevents weight gain by altering neurometabolome profiles in the hypothalamus to reduce food intake. To test this hypothesis, we assessed metabolite profiles in the hypothalamus of standard diet- or high-fat (HF) diet-fed mice in the absence or presence of VO. In total, 29 male C57BL/6 mice were divided into 3 groups: (1) lean control, (2) HF, and (3) HF + VO. Vehicle or VO was administered for 12 weeks. The results showed that there were alterations in levels of metabolites across several metabolic pathways in the hypothalamus. VO treatment increased levels of many amino acids including arginine, glutamine, histidine, isoleucine, leucine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, and valine in the hypothalamus. In addition, levels of 2-hydroxy-2-methyl-butyric acid in the hypothalamus were significantly increased after VO administration in HF diet-fed mice. Among lipid metabolites, levels of fatty acids were higher in the hypothalamus of VO-treated mice than in th...Continue Reading
References
Apr 16, 1998·Diabetes Care·K MatsumotoY Tominaga
Sep 29, 1999·Journal of Neurochemistry·C BlázquezM Guzmán
Jan 29, 2002·Diabetes·Silvana ObiciLuciano Rossetti
Nov 22, 2002·The Journal of Biological Chemistry·Changhong LiCharles A Stanley
Aug 23, 2003·Endocrinology·Jeffrey M Zigman, Joel K Elmquist
May 25, 2004·The Journal of Biological Chemistry·Kimyata MorganLuciano Rossetti
Dec 24, 2004·Diabetes Care·Floris A van de LaarChris van Weel
Jan 22, 2005·Seminars in Cell & Developmental Biology·Scot R Kimball, Leonard S Jefferson
May 16, 2008·The Journal of Biological Chemistry·Sharon E Malmberg, Christopher M Adams
Oct 14, 2011·Journal of Clinical Gastroenterology·George T Macfarlane, Sandra Macfarlane
May 16, 2012·Orphanet Journal of Rare Diseases·Amanda J HeslegraveKhalid Hussain
Jul 14, 2012·Molecular and Cellular Endocrinology·Romana StarkZane B Andrews
Dec 26, 2012·Frontiers in Neuroscience·Marc Schneeberger, Marc Claret
Jan 1, 2014·Diabetes·Christelle Le FollBarry E Levin
Jan 7, 2014·Advances in Immunology·Jian TanLaurence Macia
Jan 7, 2014·Biochemical and Biophysical Research Communications·Hyun Ju DoMin-Jeong Shin
Jan 17, 2014·Journal of Korean Medical Science·Mi Young LeeHee Kang Shin
May 2, 2014·Nature Communications·Gary FrostJimmy D Bell
May 7, 2014·Expert Opinion on Pharmacotherapy·Kohei Kaku
Jun 25, 2014·Nature Reviews. Endocrinology·Susan MurrayNicole M Avena
Jan 7, 2015·BMB Reports·Jong-Woo Sohn
Apr 22, 2015·Neurobiology of Aging·Ai-Ling LinLora Watts
Jan 19, 2016·Diabetes & Metabolic Syndrome·Praful A TalaviyaSneha V Ghadiya
Mar 5, 2016·Journal of the International Society of Sports Nutrition·Peter Bond
Apr 18, 2016·Metabolism: Clinical and Experimental·Olivia M FarrChristos S Mantzoros
Apr 29, 2016·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Christelle Le Foll, Barry E Levin
Jun 28, 2016·Neurochemistry International·Roman M StillingJohn F Cryan
Jun 29, 2016·Endocrine Journal·Hyun Ju DoMin-Jeong Shin
Aug 25, 2016·Clinical Science·Pablo B Martínez de MorentinMiguel López
Sep 1, 2016·CNS & Neurological Disorders Drug Targets·Tae Seok OhEun-Kyoung Kim
Oct 7, 2016·Scientific Reports·Lionel CarneiroLuc Pellerin
Nov 9, 2016·Neurochemical Research·Lavanya B Achanta, Caroline D Rae
May 21, 2017·Scientific Reports·Enshuang GuoXiaojing Jiang
May 27, 2017·The Biochemical Journal·Stefan Bröer, Angelika Bröer
Jun 19, 2017·Neuropeptides·Yusaku IwasakiToshihiko Yada